Myomo (MYO) Projected to Post Earnings on Wednesday

Myomo (NYSEAMERICAN:MYO - Get Free Report) is expected to be announcing its Q1 2025 earnings results after the market closes on Wednesday, May 7th. Analysts expect the company to announce earnings of ($0.08) per share and revenue of $9.22 million for the quarter.

Myomo Price Performance

Shares of NYSEAMERICAN:MYO traded down $0.02 during midday trading on Tuesday, reaching $4.72. The company had a trading volume of 170,650 shares, compared to its average volume of 415,662. The stock has a market cap of $142.63 million, a PE ratio of -20.50 and a beta of 1.68. The company's fifty day simple moving average is $4.85. Myomo has a one year low of $2.76 and a one year high of $7.17.

Analyst Ratings Changes

A number of research analysts have recently issued reports on MYO shares. Alliance Global Partners restated a "buy" rating on shares of Myomo in a research report on Tuesday, March 11th. Craig Hallum upped their price objective on shares of Myomo from $9.00 to $11.00 and gave the stock a "buy" rating in a report on Tuesday, March 11th. HC Wainwright lifted their price target on Myomo from $7.50 to $9.50 and gave the company a "buy" rating in a research report on Wednesday, March 12th. Finally, Ascendiant Capital Markets lifted their price target on shares of Myomo from $9.00 to $11.00 and gave the stock a "buy" rating in a research report on Monday, March 17th. Five analysts have rated the stock with a buy rating, According to MarketBeat.com, the company presently has a consensus rating of "Buy" and a consensus target price of $9.75.

Insiders Place Their Bets

In related news, Director Thomas F. Kirk purchased 7,400 shares of the firm's stock in a transaction dated Thursday, March 13th. The stock was bought at an average price of $5.00 per share, for a total transaction of $37,000.00. Following the purchase, the director now owns 255,933 shares in the company, valued at $1,279,665. The trade was a 2.98 % increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Micah Mitchell sold 48,000 shares of the stock in a transaction that occurred on Friday, March 14th. The shares were sold at an average price of $5.16, for a total value of $247,680.00. Following the transaction, the insider now owns 140,572 shares in the company, valued at approximately $725,351.52. This trade represents a 25.45 % decrease in their position. The disclosure for this sale can be found here. Insiders own 4.54% of the company's stock.

About Myomo

Myomo, Inc, a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living.